Drugs / trivalent inactivated influenza vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01419925 Background | Aug 2011 → Jan 2012 | influenza | BiondVax Pharmaceuticals ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | trivalent inactivated influenza vaccine | “before receiving the trivalent inactivated influenza vaccine (TIV).” PMID 25173483 ↗ Aug 2014 |
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01419925 ↗ |
| Modality | Vaccine | “trivalent inactivated influenza vaccine (TIV)” NCT01419925 ↗ |